Basics of Chimeric Antigen Receptor (CAR) Immunotherapy presents
the latest on how T cell adoptive immunotherapy has progressed in
its ultimate goal of curing metastatic malignant cancers. Recent
clinical data obtained with checkpoint receptor blockade inhibitors
and chimeric antigen receptor (CAR) therapy has been especially
promising, thus generating renewed hope that we may be on the verge
of finally curing cancer. Over the years, huge progress has been
made in controlling several stage IV metastasized cancers through
the clinical application of checkpoint receptor inhibitory drugs
and CAR-Therapy that has seen unprecedented interest in the
immunotherapy field.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!